Research of New Bacteria That Show Zones of Inhibition Against non-pathogenic strain of ESKAPE Pathogen
Location
CoLab, OCB 100
Start Date
28-4-2017 11:00 AM
End Date
28-4-2017 12:45 PM
Document Type
Poster
Description
The importance of continuously researching new bacteria that produce a potentially new antibiotic against ESKAPE pathogens is vital because, as a whole, we are running out of antibiotics to treat patients who are infected with one of these antibiotic resistant pathogens. To find bacteria that have an antibiotic resistance against one or more pathogens, I took a sample of soil from North Kansas City, MO, diluted the soil, and identified colonies of bacteria that have zones of inhibition or halos and may be a potential candidate for one or more of the ESKAPE pathogens. I gathered a total of 10 candidates and numbered them as follows: 1, 2, 22, 3, 32, P2, P2, P3, P3 and P4. Three out of the ten candidates had shown an inhibition against a pathogen. 22 inhibited Mycobacterium smegmatis and Staphylococcus aureus, P2 inhibited Escherichia coli, and P3 inhibited Escherichia coli and Mycobacterium smegmatis. Finding these candidates that shows a zone of inhibition to one of the pathogens could potentially allow us to develop a new antibiotic against an ESKAPE pathogen.
Image
Research of New Bacteria That Show Zones of Inhibition Against non-pathogenic strain of ESKAPE Pathogen
CoLab, OCB 100
The importance of continuously researching new bacteria that produce a potentially new antibiotic against ESKAPE pathogens is vital because, as a whole, we are running out of antibiotics to treat patients who are infected with one of these antibiotic resistant pathogens. To find bacteria that have an antibiotic resistance against one or more pathogens, I took a sample of soil from North Kansas City, MO, diluted the soil, and identified colonies of bacteria that have zones of inhibition or halos and may be a potential candidate for one or more of the ESKAPE pathogens. I gathered a total of 10 candidates and numbered them as follows: 1, 2, 22, 3, 32, P2, P2, P3, P3 and P4. Three out of the ten candidates had shown an inhibition against a pathogen. 22 inhibited Mycobacterium smegmatis and Staphylococcus aureus, P2 inhibited Escherichia coli, and P3 inhibited Escherichia coli and Mycobacterium smegmatis. Finding these candidates that shows a zone of inhibition to one of the pathogens could potentially allow us to develop a new antibiotic against an ESKAPE pathogen.
Comments
The faculty supervisor on this project is Heather Seitz, Biology.